Prostate Cancer Patients need earlier, safer & more effective therapy.

We are changing the conversation.

 

Developing gene-based, cost-effective Immunotherapies for men throughout the entire spectrum of prostate cancer progression: from premetastatic, to newly metastatic, to late stage metastatic disease.

Madis   n Vaccines Inc. (MVI)

                           Latest News

Dec 4, 2017 - Peer-Reviewed Paper Demonstrates How MVI-118 Works in Combination with Androgen Deprivation Therapy in Advanced Prostate Cancer

October 26, 2017 - Madison Vaccines Incorporated appoints Jeff Bailey to its Board of Directors

ABOUT

DISCOVERY

WHAT WE DO

ABOUT PROSTATE CANCER

LATEST NEWS

CONTACT US

 

ExploRE MVI

Copyright © 2017 Madison Vaccines, Inc. | Privacy Policy.